Biosimilars and the Purple Book from CorConsult Rx: Evidence-Based Medicine and Pharmacy

CorConsult Rx: Evidence-Based Medicine and Pharmacy

Mike Corvino, PharmD, BCPS, BCACP, CDCES and Cole Swanson, PharmD, CDCES

Biosimilars and the Purple Book

2 minutes Posted Dec 22, 2017 at 9:09 pm.

0:00

2:37

Share at current time

Show notes

This is a brief discussion of the Remicade biosimilars that have been approved. I also discuss the FDA's Purple Book.